262 related articles for article (PubMed ID: 24369747)
21. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation.
Ahuja A; Ali J; Rahman S
Pharmazie; 2006 Jan; 61(1):25-9. PubMed ID: 16454202
[TBL] [Abstract][Full Text] [Related]
22. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug.
Lizambard M; Menu T; Fossart M; Bassand C; Agossa K; Huck O; Neut C; Siepmann F
Int J Pharm; 2019 Dec; 572():118833. PubMed ID: 31715363
[TBL] [Abstract][Full Text] [Related]
23. Formulation development of physiological environment responsive periodontal drug delivery system for local delviery of metronidazole benzoate.
Dabhi MR; Sheth NR
Drug Dev Ind Pharm; 2013 Mar; 39(3):425-36. PubMed ID: 22393879
[TBL] [Abstract][Full Text] [Related]
24. The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method.
Park PI; Makoid M; Jonnalagadda S
Eur J Pharm Biopharm; 2011 Feb; 77(2):233-9. PubMed ID: 21145965
[TBL] [Abstract][Full Text] [Related]
25. Concomitant monitoring of implant formation and drug release of in situ forming poly (lactide-co-glycolide acid) implants in a hydrogel matrix mimicking the subcutis using UV-vis imaging.
Sun Y; Jensen H; Petersen NJ; Larsen SW; Østergaard J
J Pharm Biomed Anal; 2018 Feb; 150():95-106. PubMed ID: 29216591
[TBL] [Abstract][Full Text] [Related]
26. Asenapine maleate in situ forming biodegradable implant: an approach to enhance bioavailability.
Avachat AM; Kapure SS
Int J Pharm; 2014 Dec; 477(1-2):64-72. PubMed ID: 25305379
[TBL] [Abstract][Full Text] [Related]
27. Controlled delivery of aspirin: effect of aspirin on polymer degradation and in vitro release from PLGA based phase sensitive systems.
Tang Y; Singh J
Int J Pharm; 2008 Jun; 357(1-2):119-25. PubMed ID: 18329202
[TBL] [Abstract][Full Text] [Related]
28. Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants.
Lan SF; Kehinde T; Zhang X; Khajotia S; Schmidtke DW; Starly B
Dent Mater; 2013 Jun; 29(6):656-65. PubMed ID: 23602170
[TBL] [Abstract][Full Text] [Related]
29. Development of an in situ forming PLGA drug delivery system I. Characterization of a non-aqueous protein precipitation.
Körber M; Bodmeier R
Eur J Pharm Sci; 2008 Nov; 35(4):283-92. PubMed ID: 18721875
[TBL] [Abstract][Full Text] [Related]
30. Dual controlled release, in situ gelling periodontal sol of metronidazole benzoate and serratiopeptidase: statistical optimization and mechanistic evaluation.
Kumari N; Pathak K
Curr Drug Deliv; 2012 Jan; 9(1):74-84. PubMed ID: 22023207
[TBL] [Abstract][Full Text] [Related]
31. Effects of topical application of metronidazole-containing mucoadhesive lipogel in periodontal pockets.
Toskić-Radojicić M; Nonković Z; Loncar I; Varjacić M
Vojnosanit Pregl; 2005; 62(7-8):565-8. PubMed ID: 16171020
[TBL] [Abstract][Full Text] [Related]
32. Optimization of metronidazole sustained-release films using D-optimal design.
Peerapattana J; Ngamsupsiri T; Cheucharoenvasuchai N; Saikaew C
Int J Pharm; 2015 Apr; 484(1-2):1-7. PubMed ID: 25681726
[TBL] [Abstract][Full Text] [Related]
33. In vitro study on tamsulosin release kinetics from biodegradable PLGA in situ implants.
Elias-Al-Mamun M; Khan HA; Dewan I; Jalil RU
Pak J Pharm Sci; 2009 Oct; 22(4):360-7. PubMed ID: 19783512
[TBL] [Abstract][Full Text] [Related]
34. In-situ forming PLGA implants: Towards less toxic solvents.
Ramos F; Willart JF; Neut C; Agossa K; Siepmann J; Siepmann F
Int J Pharm; 2024 May; 657():124121. PubMed ID: 38621617
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
[TBL] [Abstract][Full Text] [Related]
36. Local antimicrobial therapies in periodontal disease.
Kinane DF
Ann R Australas Coll Dent Surg; 2000 Oct; 15():57-60. PubMed ID: 11709978
[TBL] [Abstract][Full Text] [Related]
37. Randomized, controlled, single-masked, clinical study to compare and evaluate the efficacy of microspheres and gel in periodontal pocket therapy.
Srirangarajan S; Mundargi RC; Ravindra S; Setty SB; Aminabhavi TM; Thakur S
J Periodontol; 2011 Jan; 82(1):114-21. PubMed ID: 20681818
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of mechanical and rheological properties of metronidazole gel as local delivery system.
Jelvehgari M; Montazam H
Arch Pharm Res; 2011 Jun; 34(6):931-40. PubMed ID: 21725814
[TBL] [Abstract][Full Text] [Related]
40. Effect of polylactide/glycolide (PLGA) membranes loaded with metronidazole on periodontal regeneration following guided tissue regeneration in dogs.
Kurtiş B; Unsal B; Cetiner D; Gültekin E; Ozcan G; Celebi N; Ocak O
J Periodontol; 2002 Jul; 73(7):694-700. PubMed ID: 12146527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
